PROTACs que degradan KRAS provocan regresión tumoral profunda y duradera en modelos de cáncer de pulmón, superando a inhibidores y resistencias (Cancer Research). https://aidoo.news/noticia/rvXBw2

#Oncologia #PROTAC #Investigacion #Ciencia #España

Un estudio logra una "marcada regresión" en cáncer de pulmón degradando la proteína KRAS

Investigadores del IRB Barcelona y del Centro de Investigación del Cáncer de Salamanca muestran que degradar la proteína KRAS con moléculas PROTACs provoca una

Aidoo Noticias

PROTACs que degradan KRAS provocan regresión tumoral profunda y duradera en modelos de cáncer de pulmón, superando a inhibidores y resistencias (Cancer Research). https://aidoo.news/noticia/rvXBw2

#Oncologia #PROTAC #Investigacion #Ciencia #España

Un estudio logra una "marcada regresión" en cáncer de pulmón degradando la proteína KRAS

Investigadores del IRB Barcelona y del Centro de Investigación del Cáncer de Salamanca muestran que degradar la proteína KRAS con moléculas PROTACs provoca una

Aidoo Noticias
Amazing news that the first #PROTAC for targeted protein degradation has been approved by the @[email protected]. Great to see a new modality added to the therapeutic toolbox. Very curious to see, how the field of induced proximity will develop further into the future. (1/3) news.yale.edu/2026/05/07/y...

Yale-led technology receives F...
Yale-led technology receives FDA approval for breast cancer treatment

The biotech company Arvinas was originally founded based on pioneering research from Yale chemist Craig Crews into PROTAC protein degraders.

Yale News

Amazing news that the first #PROTAC for targeted protein degradation has been approved by the FDA. Great to see an entirely new modality added to the therapeutic toolbox.

https://news.yale.edu/2026/05/07/yale-led-technology-receives-fda-approval-breast-cancer-treatment

Very curious to see, how the field of induced proximity will develop further into the future with so many additional exciting applications already shown in basic academic research. Curious, which other therapeutic areas will most profit from this development. (1/2)

Yale-led technology receives FDA approval for breast cancer treatment

The biotech company Arvinas was originally founded based on pioneering research from Yale chemist Craig Crews into PROTAC protein degraders.

Yale News

PKMYT1 is a promising target for #cancer #drug developmenent. While some inhibitors such as RP-6036 are available for some time, researchers from InSilico #Medicine have now introduced a novel #PROTAC degrader based on their computational design of a novel inhibitor. This study was now published in #Nature Communications (2025):
https://www.nature.com/articles/s41467-025-65796-8

#drugdesign #chemistry #MedicinalChemistry #research #science

🤖 Can AI help us predict and prevent off-target effects in PROTAC drug design?

🔗 Predicting PROTAC off-target effects via warhead involvement levels in drug–target interactions using graph attention neural networks. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.10.028

📚 CSBJ: https://www.csbj.org/

#DrugDevelopment #StructuralBiology #ChemicalBiology #PROTAC #DrugDiscovery #Cheminformatics #Bioinformatics #PrecisionMedicine #TargetedProteinDegradation

🧩 The future of drug discovery may depend on how well we understand PROTAC-driven protein partnerships.

🔗 Mapping the energy landscape of PROTAC-mediated protein-protein interactions. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2023.02.049

📚 CSBJ: https://www.csbj.org/

#StructuralBiology #PROTAC #DrugDiscovery #ComputationalBiology #ProteinEngineering #ProteinDegradation #Biopharma #MedicinalChemistry #TargetedTherapies #AIinBiotech #MolecularModeling

Postdoctoral Fellow

Ruijin Hospital

The new Frontiers in Therapeutics Research Laboratory is an exciting opportunity to launch your career in translational research.

See the full job description on jobRxiv: https://jobrxiv.org/job/ruijin-hospital-27778-postdoctoral-fellow/?feed_id=97619

#Cancer_Pharmacology #cell_biology #lnp_mrna #protac #ScienceJobs #hiring #research
https://jobrxiv.org/job/ruijin-hospital-27778-postdoctoral-fellow/?feed_id=97619

Postdoctoral Fellow

Post a job in 3min, or find thousands of job offers like this one at jobRxiv!

jobRxiv

Postdoctoral Fellow

Ruijin Hospital

The new Frontiers in Therapeutics Research Laboratory is an exciting opportunity to launch your career in translational research.

See the full job description on jobRxiv: https://jobrxiv.org/job/ruijin-hospital-27778-postdoctoral-fellow/?feed_id=97290

#Cancer_Pharmacology #cell_biology #lnp_mrna #protac #ScienceJobs #hiring #research
https://jobrxiv.org/job/ruijin-hospital-27778-postdoctoral-fellow/?feed_id=97290

Postdoctoral Fellow

Post a job in 3min, or find thousands of job offers like this one at jobRxiv!

jobRxiv